Bill Text: HI SB2571 | 2018 | Regular Session | Introduced

NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Relating To Water Pollution.

Spectrum: Partisan Bill (Democrat 6-0)

Status: (Passed) 2018-07-06 - Act 104, 07/03/2018 (Gov. Msg. No. 1205). [SB2571 Detail]

Download: Hawaii-2018-SB2571-Introduced.html

THE SENATE

S.B. NO.

2571

TWENTY-NINTH LEGISLATURE, 2018

 

STATE OF HAWAII

 

 

 

 

 

 

A BILL FOR AN ACT

 

 

relating to WATER POLLUTION.

 

 

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:

 


     SECTION 1.  The legislature finds that two chemicals contained in many sunscreens, oxybenzone and octinoxate, have significant harmful impacts on Hawaii's marine environment and residing ecosystems, including coral reefs that protect Hawaii's shoreline.  Oxybenzone and octinoxate cause mortality in developing coral; increase coral bleaching that indicates extreme stress, even at temperatures below 87.8 degrees Fahrenheit; and cause genetic damage to coral and other marine organisms.  These chemicals have also been shown to degrade corals' resiliency and ability to adjust to climate change factors and inhibit recruitment of new corals.  Furthermore, oxybenzone and octinoxate appear to increase probability of endocrine disruption; scientific studies show that both chemicals can induce feminization in adult male fish and increase reproductive diseases in marine invertebrate species (e.g., sea urchins), vertebrate species (e.g., fish such as wrasses, eels, and parrotfish), and mammals (in species similar to the Hawaiian monk seal).  The chemicals also induce deformities in the embryonic development of fish, sea urchins, coral, and shrimp and induce neurological behavioral changes in fish that threaten the continuity of fish populations.  In addition, species that are listed on the federal Endangered Species Act and inhabit Hawaii's waters, including sea turtle species, marine mammals, and migratory birds, may be exposed to oxybenzone and octinoxate contamination.

     The legislature further finds that environmental contamination of oxybenzone and octinoxate persists in Hawaii's coastal waters, as the contamination is constantly refreshed and renewed every day by swimmers and beachgoers.  Swimming and other water activities cause these chemicals to pollute Hawaii's water unless they are actively mitigated.  Sewage contamination of coastal waters is another source of oxybenzone and octinoxate environmental contamination, as these chemicals are not removed by the State's wastewater treatment system.  Oxybenzone and octinoxate are also discharged to the ground and surface waters from cesspools, leaking septic systems, and municipal wastewater collection and treatment systems.  The legislature additionally finds that elevated levels of oxybenzone and octinoxate have been detected at popular swimming beaches and critical coral reef areas throughout the State, including Waimea bay, Hanauma bay, and Waikiki beach on Oahu, and Honolua bay and Ahihi nature reserve area on Maui.

     Accordingly, the purpose of this Act is to preserve marine ecosystems, including coral reefs, by prohibiting the sale in Hawaii of ultraviolet sun protection factor sunscreen personal care products containing oxybenzone and octinoxate.

     SECTION 2.  Chapter 342D, Hawaii Revised Statutes, is amended by adding a new section to part I to be appropriately designated and to read as follows:

     "§342D-    Sale of sunscreen products containing oxybenzone or octinoxate, or both; prohibition.  (a)  It shall be unlawful to sell, offer for sale, or distribute for sale in the State any SPF sunscreen protection personal care product that contains oxybenzone or octinoxate, or both, without a medically-licensed prescription.

     (b)  For purposes of this section:

     "Octinoxate" refers to the chemical ((RS)-2-Ethylhexyl (2E)-3-(4-methoxyphenyl)prop-2-enoate under the International Union of Pure and Applied Chemistry chemical nomenclature registry; that has a chemical abstract service registry number 5466-77-3; whose synonyms include but are not limited to ethylhexyl methoxycinnamate, octyl methoxycinnamate, Eusolex 2292, Neo Heliopan AV, NSC 26466, Parsol MOX, Parasol MCX, Parsol MOX, and Uvinul MC80; and is intended to be used as protection against ultraviolet light radiation with a spectrum wavelength from 370 nanometers to 220 nanometers in an SPF sunscreen protection personal care product.

     "Oxybenzone" refers to the chemical (2-Hydroxy-4-methoxyphenyl)-phenylmethanone under the International Union of Pure and Applied Chemistry chemical nomenclature registry; that has a chemical abstract service registry number 131-57-7; whose synonyms include but are not limited to benzophenone-3, Escalol 567, Eusolex 4360, KAHSCREEN BZ-3, Uvasorb MET/C, Syntase 62, UV 9, Uvinul 9, Uvinul M-40, Uvistat 24, USAF Cy-9, Uniphenone-3U, 4-methoxy-2-hydroxybenzophenone and Milestab 9; and is intended to be used as protection against ultraviolet light radiation with a spectrum wavelength from 370 nanometers to 220 nanometers in an SPF sunscreen protection personal care product.

     "SPF sunscreen protection personal care product" includes but is not limited to lotion, paste, balm, ointment, cream, solid stick applicator, brush applicator, roll-on applicator, aerosol spray, non-aerosol spray pump, and automated and manual mist spray."

     SECTION 3.  This Act does not affect rights and duties that matured, penalties that were incurred, and proceedings that were begun before its effective date.

     SECTION 4.  New statutory material is underscored.

     SECTION 5.  This Act shall take effect on January 1, 2019.

 

INTRODUCED BY:

_____________________________

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 


 

Report Title:

Environment; Sunscreen Protection Personal Care Products; Oxybenzone; Octinoxate; Sale; Prohibition

 

Description:

Bans the sale, offer of sale, or distribution in the State of any SPF sunscreen protection personal care product that contains oxybenzone or octinoxate, or both, without a medically-licensed prescription.  Takes effect 1/1/2019.

 

 

 

The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.

feedback